RecruitingNCT06659029

Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users

Studying Pediatric systemic lupus erythematosus

Last synced from ClinicalTrials.gov May 17, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: AstraZeneca
Intervention: Anifrolumab(drug)
Enrollment: 442 target
Eligibility: FEMALE
Timeline: 2025 – 2031

Study locations (1)

Research Site, Wilmington, North Carolina, United States

Collaborators

PPD Development, LP

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06659029 on ClinicalTrials.gov

Other trials for Pediatric systemic lupus erythematosus

Additional recruiting or active studies for the same condition.

RECRUITINGNCT07425730
Early Myocardial Dysfunction Helps Identify Severe Refractory Pediatric Lupus
Shanghai Jiao Tong University School of Medicine
RECRUITINGEARLY PHASE1NCT07339332
A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Dynamics of Universal CD19 / 20 Car-t Cell Injection in Moderate to Severe Refractory Systemic Lupus Erythematosus
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGPHASE1NCT07109986
UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus Nephritis
Nanjing IASO Biotechnology Co., Ltd.
ACTIVE NOT RECRUITINGNANCT07196072
A Multi-component, Person-centered, and Yoga-based Coaching Program for Lupus Chronic Pain
University of Michigan
RECRUITINGNCT07128966
Direct to Patient Minimal Risk Biospecimen and Data Collection Research
Joined Bio
RECRUITINGPHASE1NCT06613360
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
Cullinan Therapeutics Inc.
RECRUITINGNCT07017868
Correlation Between Serum Uric Acid, Serum Homocysteine Level and Interleukin- 17 in Lupus Nephritis Patients
Sohag University
RECRUITINGEARLY PHASE1NCT06711146
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Moderate to Severe Active SLE Clinical Research
Zhejiang University

See all trials for Pediatric systemic lupus erythematosus →

← Back to all trials